Opaleye Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.8M Buy
2,860,000
+7,930
+0.3% +$113K 8.25% 2
2025
Q1
$37M Hold
2,852,070
8.24% 2
2024
Q4
$38M Buy
2,852,070
+72,070
+3% +$960K 6.65% 4
2024
Q3
$16.7M Buy
2,780,000
+385,000
+16% +$2.31M 2.78% 10
2024
Q2
$7.88M Sell
2,395,000
-50,781
-2% -$167K 1.8% 16
2024
Q1
$9.17M Sell
2,445,781
-84,106
-3% -$315K 2% 17
2023
Q4
$11.1M Buy
2,529,887
+99,617
+4% +$436K 2.95% 9
2023
Q3
$10.1M Buy
2,430,270
+145,270
+6% +$606K 3.3% 10
2023
Q2
$7.97M Buy
2,285,000
+100,000
+5% +$349K 1.91% 12
2023
Q1
$8.41M Buy
2,185,000
+15,000
+0.7% +$57.8K 2.52% 9
2022
Q4
$6.12M Sell
2,170,000
-351,000
-14% -$990K 2.13% 15
2022
Q3
$5.29M Buy
2,521,000
+58,500
+2% +$123K 2.19% 15
2022
Q2
$6.45M Buy
2,462,500
+83,225
+3% +$218K 2.91% 13
2022
Q1
$10.4M Sell
2,379,275
-5,725
-0.2% -$25K 3.22% 11
2021
Q4
$10.2M Sell
2,385,000
-703,100
-23% -$3.02M 2.17% 15
2021
Q3
$15.6M Sell
3,088,100
-604,500
-16% -$3.05M 2.91% 10
2021
Q2
$29.3M Sell
3,692,600
-347,400
-9% -$2.76M 4.87% 6
2021
Q1
$29.6M Hold
4,040,000
4.34% 6
2020
Q4
$32.8M Buy
4,040,000
+400,000
+11% +$3.25M 4.29% 4
2020
Q3
$28.8M Hold
3,640,000
5.62% 3
2020
Q2
$19.8M Hold
3,640,000
4.01% 5
2020
Q1
$14.9M Buy
3,640,000
+2,170,544
+148% +$8.9M 3.95% 8
2019
Q4
$10.6M Buy
1,469,456
+304,456
+26% +$2.19M 2.08% 20
2019
Q3
$7.36M Buy
1,165,000
+90,000
+8% +$569K 2.66% 18
2019
Q2
$8.49M Buy
1,075,000
+310,227
+41% +$2.45M 2.59% 17
2019
Q1
$6.12M Buy
764,773
+241,773
+46% +$1.93M 1.69% 25
2018
Q4
$3.2M Buy
+523,000
New +$3.2M 1.19% 26